Latest Breaking News On - Benitec biopharma daily - Page 2 : comparemela.com

Benitec Biopharma (NASDAQ:BNTC) PT Raised to $8 00 at JMP Securities

Benitec Biopharma (NASDAQ:BNTC – Free Report) had its target price boosted by JMP Securities from $6.00 to $8.00 in a report released on Wednesday, Benzinga reports. The firm currently has a market outperform rating on the biotechnology company’s stock. Benitec Biopharma Trading Up 4.4 % NASDAQ:BNTC opened at $3.07 on Wednesday. The stock has a […]

Benitec biopharmaRenaissance technologiesBenitec biopharma incVirtu financialMillennium managementMorgan stanleyFree reportGet free reportAdage capital partnersBiopharma incBenitec biopharma dailyNasdaq bntcBoost price targetJmp securities

JMP Securities Raises Benitec Biopharma (NASDAQ:BNTC) Price Target to $8 00

Benitec Biopharma (NASDAQ:BNTC – Get Free Report) had its price objective upped by equities research analysts at JMP Securities from $6.00 to $8.00 in a research report issued on Wednesday, Benzinga reports. The firm currently has a “market outperform” rating on the biotechnology company’s stock. JMP Securities’ price objective indicates a potential upside of 166.67% […]

Benitec biopharmaBenitec biopharma incVirtu financialMorgan stanleyMillennium managementRenaissance technologiesGet free reportAdage capital partnersBiopharma incBenitec biopharma dailyNasdaq bntcBoost price targetJmp securities

JMP Securities Raises Benitec Biopharma (NASDAQ:BNTC) Price Target to $8 00

JMP Securities Raises Benitec Biopharma (NASDAQ:BNTC) Price Target to $8 00
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

Benitec biopharmaVirtu financialBenitec biopharma incRenaissance technologiesMillennium managementMorgan stanleyGet free reportCapital partnersBiopharma incBenitec biopharma daily

Benitec Biopharma Inc (NASDAQ:BNTC) Short Interest Down 28 2% in November

Benitec Biopharma Inc. (NASDAQ:BNTC – Get Free Report) was the recipient of a large drop in short interest during the month of November. As of November 15th, there was short interest totalling 33,400 shares, a drop of 28.2% from the October 31st total of 46,500 shares. Currently, 1.5% of the company’s shares are sold short. […]

Benitec biopharmaMorgan stanleyBenitec biopharma company profileRenaissance technologiesMillennium managementBenitec biopharma incVirtu financialGet free reportCapital partnersBiopharma incBenitec biopharma dailyNasdaq bntc

Benitec Biopharma (NASDAQ:BNTC) Price Target Raised to $6 50

Benitec Biopharma (NASDAQ:BNTC – Free Report) had its price target raised by JMP Securities to $6.50 in a research report released on Tuesday morning, Marketbeat reports. They currently have a market outperform rating on the biotechnology company’s stock. Benitec Biopharma Trading Down 1.6 % Shares of BNTC stock opened at $3.02 on Tuesday. The company […]

Benitec biopharmaBenitec biopharma incRenaissance technologiesMorgan stanleyVirtu financialBenitec biopharma company profileMillennium managementFree reportBiopharma trading downGet free reportBiopharma incBenitec biopharma dailyNasdaq bntcBoost price targetJmp securities